$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Randomized Clinical Trial: The Clinical Effects of Herb-Partitioned Moxibustion in Patients with Diarrhoea-Predominant Irritable Bowel Syndrome 원문보기

Evidence-based Complementary and Alternative Medicine : eCAM, v.2013, 2013년, pp.605460 -   

Ma, Yu-xia (Shandong University of Traditional Chinese Medicine, Shandong, Jinan 250014, China) ,  Liu, Xiao (Shandong University of Traditional Chinese Medicine, Shandong, Jinan 250014, China) ,  Liu, Cun-zhi (Beijing Hospital of Traditional Chinese Medicine Affiliated to Capital Medicine University, Beijing 10010, China) ,  Wang, Lin-peng (Beijing Hospital of Traditional Chinese Medicine Affiliated to Capital Medicine University, Beijing 10010, China) ,  Guo, Gang (Qilu Hospital Affiliated to Shandong University, Shandong, Jinan 250012, China) ,  Du, Dong-qing (Shandong University of Traditional Chinese Medicine, Shandong, Jinan 250014, China) ,  Wang, Zhi-lei (Shandong University of Traditional Chinese Medicine, Shandong, Jinan 250014, China) ,  Ma, Hong (Shandong University of Traditional Chinese Medicine, Shandong, Jinan 250014, China) ,  Qi, Ping (Shandong University of Traditional Chinese Medicine, Shandong, Jinan 250014, China) ,  Li, Zhao-feng (Shandong University of Traditional Chinese Medicine, Shandong, Jinan 250014, China) ,  Guo, Yan-ping (Qianfoshan Hospital Affiliated to Shandong University, Shandong, Jinan 250014, China) ,  Yi, Hua-qiang (Shandon) ,  Gao, Shu-zhong

Abstract AI-Helper 아이콘AI-Helper

Objective. To explore the efficacy of Herb-partitioned moxibustion in treating IBS-D patients. Method. 210 IBS-D patients were randomly assigned on a 3 : 3 : 2 basis to group HM, group FM, or group PB for 4-week treatment. The change of GSRS total score at weeks 4 and 8, the changes of GSRS specific...

참고문헌 (24)

  1. 1 Brandt LJ Chey WD Foxx-Orenstein AE An evidence-based position statement on the management of irritable bowel syndrome American Journal of Gastroenterology 2009 104 S1 S35 

  2. 2 Lacy BE Weiser K Noddin L Irritable bowel syndrome: patients’ attitudes, concerns and level of knowledge Alimentary Pharmacology and Therapeutics 2007 25 11 1329 1341 2-s2.0-34248545331 17509101 

  3. 3 Williams EA Stimpson J Wang D Clinical trial: a multistrain probiotic preparation significantly reduces symptoms of irritable bowel syndrome in a double-blind placebo-controlled study Alimentary Pharmacology and Therapeutics 2009 29 1 97 103 2-s2.0-57649196020 18785988 

  4. 4 Spiller R Aziz Q Creed F Guidelines on the irritable bowel syndrome: mechanisms and practical management Gut 2008 56 12 1770 1798 

  5. 5 Drossman DA Camilleri M Mayer EA Whitehead WE AGA technical review on irritable bowel syndrome Gastroenterology 2002 123 6 2108 2131 2-s2.0-0036893761 12454866 

  6. 6 Zakko S Barton G Weber E Dunger-Baldauf C Rühl A Randomised clinical trial: the clinical effects of a novel neurokinin receptor antagonist, DNK333, in women with diarrhoea-predominant irritable bowel syndrome Alimentary Pharmacology and Therapeutics 2011 33 12 1311 1321 2-s2.0-79956138710 21507028 

  7. 7 Dorn SD Kaptchuk TJ Park JB A meta-analysis of the placebo response in complementary and alternative medicine trials of irritable bowel syndrome Neurogastroenterology and Motility 2007 19 8 630 637 2-s2.0-34447517730 17640177 

  8. 8 Koloski NA Talley NJ Huskic SS Boyce PM Predictors of conventional and alternative health care seeking for irritable bowel syndrome and functional dyspepsia Alimentary Pharmacology and Therapeutics 2003 17 6 841 851 2-s2.0-0037444986 12641507 

  9. 9 van Tilburg MAL Palsson OS Levy RL Complementary and alternative medicine use and cost in functional bowel disorders: a six month prospective study in a large HMO BMC Complementary and Alternative Medicine 2008 8, article 46 2-s2.0-49249086590 

  10. 10 Manheimer E Wieland LS Cheng K Acupuncture for irritable bowel syndrome: systematic review and meta-analysis American Journal of Gastroenterology 2012 107 6 835 847 2-s2.0-84859379037 22488079 

  11. 11 Rahimi R Abdollahi M Herbal medicines for the management of irritable bowel syndrome: a comprehensive review World Journal of Gastroenterology 2012 18 7 589 600 2-s2.0-84857410412 22363129 

  12. 12 Drossman DA Rome III: The Functional Gastrointestinal Disorders 2006 3rd edition mcLean, Va, USA Degnon Associates 

  13. 13 Boyer JC Magous R Christen MO Balmes JL Bali JP Contraction of human colonic circular smooth muscle cells is inhibited by the calcium channel blocker pinaverium bromide Cell Calcium 2001 29 6 429 438 2-s2.0-0034987823 11352508 

  14. 14 Svedlund J Sjodin I Dotevall G GSRS—a clinical rating scale for gastrointestinal symptoms in patients with irritable bowel syndrome and peptic ulcer disease Digestive Diseases and Sciences 1988 33 2 129 134 2-s2.0-0023832668 3123181 

  15. 15 Dimenäs E Glise H Hallerback B Hernqvist H Svedlund J Wiklund I Quality of life in patients with upper gastrointestinal symptoms. An improved evaluation of treatment regimens? Scandinavian Journal of Gastroenterology 1993 28 8 681 687 2-s2.0-0027204257 8210982 

  16. 16 Wu HG Wang JH Chen HP Exploration of efficacy and immunological mechanism for IBS treated by herb-partition moxibustion Zhong Guo Zhen Jiu 1996 16 43 45 

  17. 17 Zhou E-H Liu H-R Wu H-G Herb-partition moxibustion relieves chronic visceral hyperalgesia and 5-HT concentration in colon mucosa of rats Neurological Research 2009 31 7 734 737 2-s2.0-68849092829 19108755 

  18. 18 Saito YA Schoenfeld P Locke GR III The epidemiology of irritable bowel syndrome in North America: a systematic review American Journal of Gastroenterology 2002 97 8 1910 1915 2-s2.0-0036678922 12190153 

  19. 19 Wilson A Longstreth GF Knight K Quality of life in managed care patients with irritable bowel syndrome Managed Care Interface 2004 17 2 24 34 2-s2.0-1142298618 

  20. 20 Longstreth GF Thompson WG Chey WD Houghton LA Mearin F Spiller RC Functional bowel disorders Gastroenterology 2006 130 5 1480 1491 2-s2.0-33646201684 16678561 

  21. 21 Park JM Choi M-G Kim YS Quality of life of patients with irritable bowel syndrome in Korea Quality of Life Research 2009 18 4 435 446 2-s2.0-63949084980 19247807 

  22. 22 Drossman DA Chey WD Johanson JF Clinical trial: lubiprostone in patients with constipation-associated irritable bowel syndrome—results of two randomized, placebo-controlled studies Alimentary Pharmacology and Therapeutics 2009 29 3 329 341 2-s2.0-58149103805 19006537 

  23. 23 Simrén M Öhman L Olsson J Clinical trial: the effects of a fermented milk containing three probiotic bacteria in patients with irritable bowel syndrome - A randomized, double-blind, controlled study Alimentary Pharmacology and Therapeutics 2010 31 2 218 227 2-s2.0-72949103471 19863495 

  24. 24 Clavé P Acalovschi M Triantafillidis JK Randomised clinical trial: otilonium bromide improves frequency of abdominal pain, severity of distention and time to relapse in patients with irritable bowel syndrome Alimentary Pharmacology and Therapeutics 2011 34 4 432 442 2-s2.0-79960563170 21679214 

섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로